InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the full record of transactions filed by Nussbaum Robert L, Directeur Médical. Insider active across 1 companies, notably Invitae Corp. In total, 13 disclosures have been logged. Total volume traded: €1.5m. The latest transaction was filed on 17 May 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€22,0276,098 shares@ €3.61221.3% of flow
Common Stock
SEC:0000899243-22-018871:0·
0168,511 shares0
Common Stock
SEC:0000899243-22-014563:0·
014,705 shares0
Common Stock
SEC:0000899243-22-011321:0·
€114,36913,269 shares@ €8.619213.7% of flow
Common Stock
SEC:0000899243-21-044611·
€114,36913,269 shares@ €8.61926.8% of flow
Common Stock
SEC:0000899243-21-044611:0·
€2,0071,666 shares@ €1.20460.2% of flow
Common Stock
SEC:0000899243-21-033857·
€2,0071,666 shares@ €1.20460.1% of flow
Common Stock
SEC:0000899243-21-033857:0·
€458,09421,231 shares@ €21.576755.0% of flow
Common Stock
SEC:0000899243-21-033561·
€458,09421,231 shares@ €21.576727.1% of flow
Common Stock
SEC:0000899243-21-033561:0·
€258,5379,910 shares@ €26.088531.0% of flow
Common Stock
SEC:0000899243-21-024194·
€258,5379,910 shares@ €26.088515.3% of flow
Common Stock
SEC:0000899243-21-024194:0·
044,700 shares0
Common Stock
SEC:0000899243-21-018205·
044,700 shares0
Common Stock
SEC:0000899243-21-018205:0·
13 of 13 declarations
About Nussbaum Robert L
Robert L. Nussbaum is the Chief Medical Officer at Invitae Corp. He oversees the company's medical and scientific initiatives, focusing on innovation in the field of genetics. His role is crucial for developing new tests and solutions, thereby contributing to Invitae's mission of making genetics accessible to all.
